ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,094, issued on March 31, was assigned to University of Florida Research Foundation Inc. (Gainesville, Fla.).

"Compounds for the treatment of neurodegenerative and metabolic disorders" was invented by Corinne Lasmezas (Palm Beach Gardens, Calif.), Minghai Zhou (Jupiter, Fla.) and Thomas D. Bannister (Palm Beach Gardens, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds described herein may be used for the treatment of neurodegenerative diseases linked to protein misfolding, including prion diseases, Alzheimer's disease, Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS), and also other neurodegenerative, degenerative, metab...